Mouin Rabbani and Nathan Thrall talk to Adam Shatz about Israel’s vaccination programme, the system of apartheid that now effectively exists between the River Jordan and the Mediterranean Sea, the legacy of Trump’s policies, and how the Biden administration may or may not exert its influence.
Catherine Moore, a consultant clinical virologist at Public Health Wales, and Rupert Beale, a clinician scientist group leader at the Francis Crick Institute, talk to Thomas Jones about the vaccine rollout for Sars-CoV-2, the new variant originally found in Brazil, and whether the virus might ever be eliminated.
Mary-Kay Wilmers, who retired as editor of the LRB last month, talks to Andrew O’Hagan about her career, first at Faber and Faber, then the Listener, then for 42 years at the London Review of Books. She talks about working with T.S. Eliot, the importance of being teased, and how a joke by Alan Bennett changed her life.
Raphaëlle Branche talks to Adam Shatz about her new book, Papa, qu’as-tu fait en Algérie? (Daddy, What Did You Do in Algeria?). In it, Branche investigates the experiences of French conscripts in the Algerian war, what they saw and did, and, more importantly, how they did and didn’t talk about it afterwards.
Erin Maglaque talks to Thomas Jones about abortion in 16th-century Italy, the stories of women who experienced it, how it was investigated, and why attitudes to pregnancy 400 years ago were in some ways preferable to those now.
Rupert Beale talks to Thomas Jones about the new Sars-CoV-2 vaccines, how the mRNA technology works, why social distancing still matters, and why he’s worried about Christmas. (The conversation was recorded before the publication of the AstraZeneca/Oxford trial data.)
Ange Mlinko talks to Joanne O’Leary about the work of Denise Riley, following the publication last year of Riley’s Selected Poems: 1976-2016 and her essay Time Lived, without Its Flow. They look in particular at Riley’s celebrated poem ‘A Part Song’, a long elegy for her adult son, Jacob, who died from undiagnosed cardiomyopathy in 2008.